(Q44479341)

3 December 2017

title

Clinical Trial Educator program - a novel approach to accelerate enrollment in a phase III International Acute Coronary Syndrome Trial (English)

1 reference

3 December 2017

main subject

phase III clinical trial

0 references

acute coronary syndrome

1 reference

Brigitte Kendall

1

1 reference

3 December 2017

Reto Städeli

2

1 reference

3 December 2017

Belinda Schegg

3

1 reference

3 December 2017

Martin Olbrich

4

1 reference

3 December 2017

Edmond Chen

5

1 reference

3 December 2017

Rona Harmelin-Kadouri

6

1 reference

3 December 2017

Peter Aurup

7

1 reference

3 December 2017

Tilmann Schwab

8

1 reference

3 December 2017

Steven K Hildemann

9

1 reference

3 December 2017

publication date

16 March 2012

1 reference

3 December 2017

1 reference

3 December 2017

volume

9

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

358-366

1 reference

Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

Early versus delayed, provisional eptifibatide in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

Recruitment experience in clinical trials: literature summary and annotated bibliography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

Clinical trials: the challenge of recruitment and retention of participants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

Marketing and clinical trials: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

Strategies for improving patient recruitment to focus groups in primary care: a case study reflective paper using an analytical framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

Overcoming subject recruitment challenges: strategies for successful collaboration with novice research agencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

Workflow to improve patient recruitment for clinical trials within hospital information systems - a case-study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

Determinants of patient recruitment in a multicenter clinical trials group: trends, seasonality and the effect of large studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

Strategies to enhance patient recruitment and retention in research involving patients with a first episode of mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

Patient recruitment to a randomized clinical trial of behavioral therapy for chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

Routine data from hospital information systems can support patient recruitment for clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

Protein binding of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

Successful subject recruitment for a prostate cancer behavioral intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

Using a business model approach and marketing techniques for recruitment to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774512440760

21 January 2018

Identifiers

DOI

10.1177/1740774512440760

1 reference

3 December 2017

1 reference